P

Inventor

CID-NÚÑEZ JOSÉ MARIA

ES12 patents
⚠️ This page may combine multiple inventors who share the name “CID-NÚÑEZ JOSÉ MARIA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

JANSSEN PHARMACEUTICA NV

9 patents
US10138237B2Nov 27, 2018

1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of mGluR2 receptors

JANSSEN PHARMACEUTICA NV2 citations71
US9708315B2Jul 18, 2017

1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of MGLUR2 receptors

JANSSEN PHARMACEUTICA NV5 citations69
US10537573B2Jan 21, 2020

Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

JANSSEN PHARMACEUTICA NV1 citations68
US12048696B2Jul 30, 2024

Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

JANSSEN PHARMACEUTICA NV0 citations57
US11369606B2Jun 28, 2022

Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

JANSSEN PHARMACEUTICA NV1 citations57
US11103506B2Aug 31, 2021

Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use

JANSSEN PHARMACEUTICA NV0 citations57
US10590131B2Mar 17, 2020

1,2,4-triazolo[4,3-a]pyridine compounds and their use as positive allosteric modulators of mGluR2 receptors

JANSSEN PHARMACEUTICA NV0 citations50
US10584129B2Mar 10, 2020

Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors

JANSSEN PHARMACEUTICA NV0 citations47
US10106542B2Oct 23, 2018

Substituted 6,7-dihydropyrazolo[1,5-a]pyrazines as negative allosteric modulators of mGluR2 receptors

JANSSEN PHARMACEUTICA NV1 citations47

CID-NÚÑEZ JOSÉ MARIA

3 patents